Suppr超能文献

吲哚美辛与庆大霉素联合预防白内障手术后炎症的疗效及耐受性

[Efficacy and tolerability of a combination of indomethacin and gentamicin for preventing inflammation after cataract surgery].

作者信息

Renard G, Adenis J P, Rouland J F, Dascotte J C, Brasseur G, Couderc J L, Hoang-Xuan T, Ullern M, Allaire C, Trinquand C

机构信息

Hôtel-Dieu, Paris.

出版信息

J Fr Ophtalmol. 1996;19(11):689-95.

PMID:9033890
Abstract

PURPOSE

The aim of the study was to compare 2 combinations of anti-inflammatory drug and antibiotic, in patients undergoing cataract surgery: 0.1% indomethacin/gentamicin or 0.1% dexamethasone/ neomycin.

METHODS

Two hundred and two patients undergoing extra-capsular cataract extraction with posterior chamber lens implantation were included in a randomized, double-blinded multicentric study comparing 2 parallel groups of treatment. Treatment was administered the day before surgery, the day of surgery and for the following 7 days. On the 8th post-operative day, the antibiotic was stopped and the anti-inflammatory treatment continued alone until the 30th post-operative day. Post-operative ocular inflammation was assessed clinically on the 1st, 7th, 15th and 30th post-operative days. The main evaluation criterion of treatment efficacy was the assessment of anterior chamber flare and cells.

RESULTS

No statistically significant difference-was observed between the 2 treatment groups concerning post-operative inflammation. Both treatments were well tolerated.

CONCLUSION

Eye drops combining 0.1% indomethacin and gentamicin proved to be effective and well tolerated in preventing inflammation after cataract surgery.

摘要

目的

本研究旨在比较两种抗炎药与抗生素的组合,用于接受白内障手术的患者:0.1%吲哚美辛/庆大霉素或0.1%地塞米松/新霉素。

方法

202例接受后房型人工晶状体植入的白内障囊外摘除术患者被纳入一项随机、双盲多中心研究,比较两个平行治疗组。治疗在手术前一天、手术当天及随后7天进行。术后第8天,停用抗生素,仅继续抗炎治疗直至术后第30天。在术后第1、7、15和30天对术后眼部炎症进行临床评估。治疗效果的主要评估标准是前房闪辉和细胞的评估。

结果

在术后炎症方面,两个治疗组之间未观察到统计学上的显著差异。两种治疗耐受性良好。

结论

事实证明,含有0.1%吲哚美辛和庆大霉素的滴眼液在预防白内障手术后的炎症方面有效且耐受性良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验